InvestorsHub Logo
Followers 23
Posts 2120
Boards Moderated 0
Alias Born 06/21/2015

Re: north40000 post# 128073

Friday, 11/03/2017 9:39:29 AM

Friday, November 03, 2017 9:39:29 AM

Post# of 461265
Welcome back... CTAD Anavex will present data to support the first precision approach to a PH 2/3 trial for a drug that is targeting the possible causes of AD.

I wonder what the reaction will be?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News